Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Delta Corp

Rakesh Jhunjhunwala Says Buy Stocks Now!



Rakesh Jhunjhunwala Says Buy Stocks Now!

Rakesh Jhunjhunwala can be trusted to give hard-hitting and sensible stock investment advice just when his disciples are feeling lost & bewildered at the downfall in the market

Rakesh Jhunjhunwala's Portfolio: Concentrated vs. Diversified



Rakesh Jhunjhunwala's Portfolio: Concentrated vs. Diversified

Rakesh Jhunjhunwala shows how a sensible investor should balance between concentration & diversification in a stock portfolio

Rakesh Jhunjhunwala Portfolio As Of March 2011



Rakesh Jhunjhunwala Portfolio As Of March 2011

Rakesh Jhunjhunwala‘s portfolio is on everybody’s mind and rightly so because no other portfolio that we know of has the number of multi-baggers that Rakesh Jhunjhunwala‘s portfolio has

Rakesh Jhunjhunwala’s Latest Portfolio, Holdings & Best Buys



Rakesh Jhunjhunwala’s Latest Portfolio, Holdings & Best Buys

Rakesh Jhunjhunwala‘s stock portfolio & holdings have the largest number of multibaggers that an investment portfolio can have. We make the astonishing discovery that if an investor had simply bought the shares that Rakesh Jhunjhunwala had bought, even after the public announcement of Rakesh Jhunjhunwala‘s purchase was made, the investor would have made a fortune

Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 509 other subscribers

RSS Stocks Talk Forum

  • Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
    Raymond Lifestyle has multiple growth drivers. It boasts legacy of established brands such as Park Avenue. However brands remain under-penetrated due to sluggish execution in past. Renewed focus on growth could lead to valuation re-rating. TP ₹3000 (+49%) Download research report... Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
  • Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr
    Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & CDMO/CMO. It is largest Indian manufacturer of Xanthines & has Global market share of 15-20% ... Sunil Singhania's Abakkus has bought 10.69L shares […]
  • PNB Housing is undergoing a transformation to morph into a franchise that will be stronger
    PNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a long-term investor. Buy for TP of ₹1160 (38% upside) Download research... PNB Housing is undergoing a transformation to morph into a franchise that will be […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!